Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Paclitaxel

Systemic allergic reaction, skin rash and facial flushing: 2 case reports

    This is a preview of subscription content, log in to check access.

    Reference

    1. Tourlaki A, et al. Paclitaxel as first- or second-line treatment for HIV-negative Kaposi's sarcoma: a retrospective study of 58 patients. Journal of Dermatological Treatment 31: 183-185, No. 2, 2020. Available from: URL: http://doi.org/10.1080/09546634.2019.1590520

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Paclitaxel. Reactions Weekly 1791, 205 (2020). https://doi.org/10.1007/s40278-020-75050-5

    Download citation